USFDA concludes inspection at Unichem Laboratories’ Ghaziabad facility

11 Mar 2019 Evaluate

United States Food and Drug Administration (USFDA) has successfully concluded the inspection at Unichem Laboratories' Ghaziabad facility. The regulator had conducted inspection at the company’s facility from March 05, 2019 to March 08, 2019. The inspection was concluded without any FDA form 483 issued.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

Unichem Lab Share Price

700.00 -13.95 (-1.95%)
09-Jan-2025 12:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1827.90
Dr. Reddys Lab 1375.95
Cipla 1492.75
Lupin 2269.95
Zydus Lifesciences 1019.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.